Ceftriaxone-related fatal hemolysis in an adolescent with perinatally acquired human immunodeficiency virus infection. J Pediatr 1998 Aug;133(2):279-81
Date
08/26/1998Pubmed ID
9709722DOI
10.1016/s0022-3476(98)70236-7Scopus ID
2-s2.0-0031928314 (requires institutional sign-in at Scopus site) 40 CitationsAbstract
A 14-year-old girl with perinatally acquired human immunodeficiency virus infection had fatal intravascular hemolysis after intravenous administration of ceftriaxone. Laboratory studies confirmed the presence of an antibody against ceftriaxone in the serum and on the patient's red blood cells. No evidence of sepsis, glucose-6-phosphate dehydrogenase deficiency or anaphylaxis was found.
Author List
Moallem HJ, Garratty G, Wakeham M, Dial S, Oligario A, Gondi A, Rao SP, Fikrig SAuthor
Martin K. Wakeham MD Professor in the Pediatrics department at Medical College of WisconsinMESH terms used to index this publication - Major topics in bold
AIDS-Related Opportunistic InfectionsAdolescent
Anemia, Hemolytic
Antibodies
Ceftriaxone
Cephalosporins
Fatal Outcome
Female
HIV Infections
Hemolysis
Humans